We are live on ! Find out more
CPA

Capital Performance Advisors Portfolio holdings

AUM $1.5B
1-Year Est. Return 21.4%
This Fund
S&P 500
This Quarter Est. Return
-0.19%
1 Year Est. Return
+21.4%
3 Year Est. Return
+61.53%
5 Year Est. Return
10 Year Est. Return
AUM
$1.5B
AUM Growth
+$85.2M
Cap. Flow
+$103M
Cap. Flow %
6.87%
Top 10 Hldgs %
42.77%
Holding
523
New
77
Increased
244
Reduced
132
Closed
54

Sector Composition

Rank Sector Weight
1 Technology 8.49%
2 Financials 3.18%
3 Consumer Discretionary 2.36%
4 Communication Services 1.8%
5 Healthcare 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MFG icon
451
Mizuho Financial
MFG
$120B
$188K 0.01%
23,632
+6,919
+41% +$58.6K
HBAN icon
452
Huntington Bancshares
HBAN
$37B
$178K 0.01%
11,392
-10,852
-49% -$185K
NMR icon
453
Nomura Holdings
NMR
$27.5B
$130K 0.01%
16,454
+3,810
+30% +$32.8K
ASAN icon
454
Asana
ASAN
$1.77B
$109K 0.01%
+16,989
New +$150K
HAFN icon
455
Hafnia
HAFN
$3.62B
$106K 0.01%
13,983
-1,140
-8% -$7.56K
ADT icon
456
ADT
ADT
$5.13B
$106K 0.01%
16,075
-19,591
-55% -$147K
PLUG icon
457
Plug Power
PLUG
$3.03B
$99.6K 0.01%
44,061
+4,923
+13% +$10.7K
NEXT icon
458
NextDecade
NEXT
$2.04B
$93.1K 0.01%
+12,148
New +$69.1K
LYG icon
459
Lloyds Banking Group
LYG
$86.6B
$87.4K 0.01%
17,385
+4,025
+30% +$22.1K
AEG icon
460
Aegon
AEG
$13.3B
$86.2K 0.01%
11,871
+1,508
+15% +$11.2K
JBLU icon
461
JetBlue
JBLU
$2.02B
$81.8K 0.01%
18,509
+144
+0.8% +$731
PLX icon
462
Protalix BioTherapeutics
PLX
$192M
$56.5K ﹤0.01%
26,051
+76
+0.3% +$189
URG
463
Ur-Energy
URG
$489M
$37.3K ﹤0.01%
+25,000
New +$40.8K
SNAP icon
464
CALL
Snap
SNAP
$7.62B
0
MIST icon
465
Milestone Pharmaceuticals
MIST
$148M
$17.6K ﹤0.01%
+14,756
New +$25.8K
BYND icon
466
Beyond Meat
BYND
$305M
$11.4K ﹤0.01%
+16,180
New +$12.9K
ALIT icon
467
Alight
ALIT
$573M
$8.77K ﹤0.01%
+752
New +$17.9K
IWM icon
468
PUT
iShares Russell 2000 ETF
IWM
$82.2B
$4.09K ﹤0.01%
+1,100
New +$284K
ACN icon
469
Accenture
ACN
$87.9B
-2,481
Closed -$666K
AIG icon
470
American International
AIG
$42.7B
-3,151
Closed -$270K
ALGN icon
471
Align Technology
ALGN
$12.7B
-1,395
Closed -$218K
ALLE icon
472
Allegion
ALLE
$11.8B
-1,407
Closed -$224K
ALNY icon
473
Alnylam Pharmaceuticals
ALNY
$35.7B
-541
Closed -$215K
AMCR icon
474
Amcor
AMCR
$20.3B
-2,049
Closed -$85.4K
AMT icon
475
American Tower
AMT
$79.2B
-2,127
Closed -$374K

Similar funds

Capital Performance Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Capital Performance Advisors held 523 positions worth $1.5B, up 6% from $1.41B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Capital Performance Advisors deployed $103M of net new capital in Q1 2026, opening 77 new positions and adding to 244 existing holdings. Its largest new stake was iShares US Technology ETF: 11,301 shares worth $2.05M.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 8.7% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $4.18M trimmed.

  • Capital Performance Advisors's largest Q1 2026 buy was iShares US Technology ETF: 11,301 shares worth $2.05M.
  • Capital Performance Advisors added most to Dimensional International Value ETF in Q1 2026, an estimated $18.4M increase.
  • Capital Performance Advisors's biggest Q1 2026 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $4.18M.
  • Capital Performance Advisors fully exited Atlassian in Q1 2026, selling an estimated $870K.
  • Capital Performance Advisors's ten largest holdings make up 43% of its $1.5B portfolio in Q1 2026.
  • Capital Performance Advisors opened 77 new positions and closed 54 in Q1 2026.
  • Capital Performance Advisors's portfolio value rose 6% quarter-over-quarter to $1.5B.

Based on Capital Performance Advisors's 13F filing for Q1 2026, filed 7 May 2026.